Pancreatic Cancer Research

ResearcherLanzhou University Second HospitalActive in the last 2 years

Wancheng Li

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112945319. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 3

  1. Single-cell and Spatial Transcriptomics Reveal Cholesterol Metabolism Heterogeneity in Pancreatic Ductal Adenocarcinoma and Identify NSDHL as a Key Regulatory … Co-author DOI 10.21203/rs.3.rs-11313598/v1↗
  2. Glycolysis and T cell-associated gene signature predicts prognosis and therapeutic responses in pancreatic cancer. Co-author DOI 10.3389/fimmu.2026.1918556↗
  3. Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer. Co-author DOI 10.32604/or.2023.026959↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wence Zhou · 1 shared paper, 2026 · strength 0.36
  2. Yuanfei Gao · 1 shared paper, 2026 · strength 0.36
  3. Wence Zhou · 1 shared paper, 2026 · strength 0.36
  4. Bo Xu Ren · 1 shared paper, 2026 · strength 0.36
  5. Hui Zhang · 1 shared paper, 2023 · strength 0.20
  6. Wence Zhou · 1 shared paper, 2023 · strength 0.20
  7. Xin Li · 1 shared paper, 2023 · strength 0.20
  8. Shi Dong · 1 shared paper, 2023 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.